COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources....
Rheumatic Diseases/immunology, Bone Marrow Failure Disorders/diagnosis, Bone Marrow Failure Disorders/complications, Bone Marrow Failure Disorders/drug therapy, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Betacoronavirus, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control